Cite
Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight.
MLA
Svane, Maria S., et al. “Four Weeks Treatment with the GLP-1 Receptor Analogue Liraglutide Lowers Liver Fat and Concomitantly Circulating Glucagon in Individuals with Overweight.” International Journal of Obesity (2005), vol. 46, no. 11, Nov. 2022, pp. 2058–62. EBSCOhost, https://doi.org/10.1038/s41366-022-01207-y.
APA
Svane, M. S., Johannesen, H. H., Hansen, A. E., Martinussen, C., Bojsen-Møller, K. N., Hansen, M. L., Deacon, C. F., Keller, S. H., Klausen, T. L., Loft, A., Kjaer, A., Löfgren, J., Madsbad, S., Holst, J. J., & Wewer Albrechtsen, N. J. (2022). Four weeks treatment with the GLP-1 receptor analogue liraglutide lowers liver fat and concomitantly circulating glucagon in individuals with overweight. International Journal of Obesity (2005), 46(11), 2058–2062. https://doi.org/10.1038/s41366-022-01207-y
Chicago
Svane, Maria S, Helle H Johannesen, Adam E Hansen, Christoffer Martinussen, Kirstine N Bojsen-Møller, Martin Lundsgaard Hansen, Carolyn F Deacon, et al. 2022. “Four Weeks Treatment with the GLP-1 Receptor Analogue Liraglutide Lowers Liver Fat and Concomitantly Circulating Glucagon in Individuals with Overweight.” International Journal of Obesity (2005) 46 (11): 2058–62. doi:10.1038/s41366-022-01207-y.